Levetiracetam is an antiepileptic drug that was shown to be effective in various seizure types. Experience with this agent for treating status epilepticus is just emerging. To the best of our knowledge, there is no report in the literature regarding its use in children with nonconvulsive status epilepticus. We here report a liver-transplanted child with nonconvulsive status epilepticus who responded well to oral levetiracetam treatment.
Singh N., Bonham A., Fukui M.Immunosuppressive-associated leukoencephalopathy in organ transplant recipients . Transplantation. 2000;69:467-472.
2.
Erol I., Alehan F., Ozcay F., et al. Neurological complications in pediatric patients: a single center experience. Pediatr Transplant. 2007;11(2):152-159.
3.
Alehan F., Erol I., Ozcay F., et al. Posterior leukoencephalopathy syndrome in children and adolescents . J Child Neurol.2007; 22:406-413.
4.
Kaplan PWNonconvulsive status epilepticus. The Neurologist. 2005;11:348-361.
5.
Rupprecht S. , Franke K., Fitzek S., et al. Levetiracetam as a treatment option in non-convulsive status epilepticus. Epilepsy Res. 2007;73(3):238-244.
6.
Patel NC, Landan IR, Levin J., et al. The use of levetiracetam in refractory status epilepticus. Seizure. 2006;15:137-141.
7.
Rossetti AO, Bromfield EBDeterminants of success in the use of oral levetiracetam in status epilepticus . Epilepsy Behav. 2006; 8:651-654.
8.
Alehan FK, Morton LD, Pellock JMTreatment of absence status with intravenous valproate. Neurology . 1999;52(4):889-890.
